These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2199177)

  • 1. Drug-protein conjugation and its immunological consequences.
    Park BK; Kitteringham NR
    Drug Metab Rev; 1990; 22(1):87-144. PubMed ID: 2199177
    [No Abstract]   [Full Text] [Related]  

  • 2. Protein-site targeting. Diversification of the drug discovery process.
    Krantz A
    Nat Biotechnol; 1998 Dec; 16(13):1294. PubMed ID: 9853592
    [No Abstract]   [Full Text] [Related]  

  • 3. Detoxication and drug metabolism: conjugation and related systems.
    Methods Enzymol; 1981; 77():1-476. PubMed ID: 7329292
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of metabolic activation in drug toxicity.
    Hinson JA; Pumford NR; Nelson SD
    Drug Metab Rev; 1994; 26(1-2):395-412. PubMed ID: 7521825
    [No Abstract]   [Full Text] [Related]  

  • 5. Small chemicals, bioactivation, and the immune system--a fragile balance of i-tox and benefits?
    Esser C; Jux B
    Chem Biodivers; 2009 Nov; 6(11):2138-43. PubMed ID: 19937849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabonomics in pharmaceutical discovery and development.
    Robertson DG; Reily MD; Baker JD
    J Proteome Res; 2007 Feb; 6(2):526-39. PubMed ID: 17269709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug antigens and the diseases which they produce.
    Samter M
    Trans Stud Coll Physicians Phila; 1966 Jan; 33(3):171-9. PubMed ID: 5906406
    [No Abstract]   [Full Text] [Related]  

  • 8. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network.
    Zhu M; Gao L; Li X; Liu Z; Xu C; Yan Y; Walker E; Jiang W; Su B; Chen X; Lin H
    J Drug Target; 2009 Aug; 17(7):524-32. PubMed ID: 19530902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs targeting protein-protein interactions.
    Chène P
    ChemMedChem; 2006 Apr; 1(4):400-11. PubMed ID: 16892375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring drug-protein interaction.
    Yang XX; Hu ZP; Chan SY; Zhou SF
    Clin Chim Acta; 2006 Mar; 365(1-2):9-29. PubMed ID: 16199025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promiscuity: what protects us, perplexes us.
    Redinbo MR
    Drug Discov Today; 2004 May; 9(10):431-2. PubMed ID: 15109946
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental, genetic and environmental aspects of drug biotransformation and conjugation. An international meeting, Dundee, Scotland, 14-17 September 1983.
    Biochem Soc Trans; 1984 Feb; 12(1):1-105. PubMed ID: 6705977
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-binding cavities in long-lived biologics: cause for concern but also potential benefit.
    Panayotatos N
    J Clin Pharmacol; 2008 Oct; 48(10):1208-11. PubMed ID: 18812610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductive drug metabolism.
    Mc Lane KE; Fisher J; Ramakrishnan K
    Drug Metab Rev; 1983; 14(4):741-99. PubMed ID: 6352224
    [No Abstract]   [Full Text] [Related]  

  • 15. [Protein malnutrition and drug metabolism].
    Yue TL
    Sheng Li Ke Xue Jin Zhan; 1987 Jul; 18(3):246-51. PubMed ID: 3118461
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of antigens and immunological diagnostic methods in the course of extrinsic allergic alveolitis].
    Molina C; Brun J; Alache JM; Jeanneret A
    Bull Int Union Tuberc; 1976; 51(1 Pt 2):485-9. PubMed ID: 802715
    [No Abstract]   [Full Text] [Related]  

  • 18. Symposium on drug protein binding. Biochemical, pharmacokinetic and clinical implications. Stockholm, March 26--28, 1980. Abstracts.
    Acta Pharm Suec; 1980; 17(2):65-104. PubMed ID: 7446140
    [No Abstract]   [Full Text] [Related]  

  • 19. [The binding of drugs to proteins. I. General significance for drug kinetics].
    Trnavská Z; Verner P
    Cesk Farm; 1983 Mar; 32(2):88-95. PubMed ID: 6850871
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-protein interactions and their clinical significance.
    Gabourel JD
    Adv Biol Skin; 1972; 12():51-60. PubMed ID: 4579205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.